Total Payments
$9,846
2024 Payments
$1,047
Companies
32
Transactions
512
Medicare Patients
1,672
Medicare Billing
$195,619
Payment Breakdown by Category
Food & Beverage$9,605 (97.5%)
Education$241.41 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,605 | 497 | 97.5% |
| Education | $241.41 | 15 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,483 | 72 | $0 (2024) |
| Novo Nordisk Inc | $1,199 | 61 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $973.91 | 54 | $0 (2024) |
| ABBVIE INC. | $931.84 | 57 | $0 (2024) |
| Lilly USA, LLC | $903.65 | 39 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $711.01 | 32 | $0 (2022) |
| GlaxoSmithKline, LLC. | $557.29 | 30 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $459.86 | 25 | $0 (2023) |
| PFIZER INC. | $348.90 | 21 | $0 (2024) |
| Allergan, Inc. | $311.94 | 15 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,047 | 50 | AstraZeneca Pharmaceuticals LP ($232.18) |
| 2023 | $1,141 | 55 | Novo Nordisk Inc ($269.75) |
| 2022 | $1,076 | 65 | ABBVIE INC. ($227.28) |
| 2021 | $1,180 | 77 | AbbVie Inc. ($280.38) |
| 2020 | $1,125 | 61 | AstraZeneca Pharmaceuticals LP ($247.63) |
| 2019 | $1,195 | 69 | Janssen Pharmaceuticals, Inc ($160.34) |
| 2018 | $1,731 | 84 | AstraZeneca Pharmaceuticals LP ($338.32) |
| 2017 | $1,351 | 51 | Lilly USA, LLC ($362.81) |
All Payment Transactions
512 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.06 | General |
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: PAIN | ||||||
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Respiratory | ||||||
| 11/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.97 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $32.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Obesity | ||||||
| 10/10/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.28 | General |
| Category: Endocrinology | ||||||
| 10/08/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $24.62 | General |
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: RESPIRATORY | ||||||
| 08/29/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/23/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: PAIN | ||||||
| 08/15/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Diabetes | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Respiratory | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Education | In-kind items and services | $19.62 | General |
| Category: Cardio-renal | ||||||
| 07/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: Cardio-renal | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.65 | General |
| 06/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 362 | 531 | $81,275 | $44,139 |
| 2022 | 10 | 458 | 609 | $89,975 | $49,131 |
| 2021 | 8 | 427 | 586 | $93,430 | $52,678 |
| 2020 | 8 | 425 | 770 | $88,520 | $49,671 |
Total Patients
1,672
Total Services
2,496
Medicare Billing
$195,619
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 108 | 171 | $31,635 | $14,810 | 46.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 95 | 95 | $17,575 | $12,472 | 71.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 54 | 105 | $13,125 | $6,501 | 49.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 30 | $7,500 | $4,102 | 54.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 37 | $4,625 | $2,387 | 51.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 14 | 17 | $3,145 | $1,753 | 55.7% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 33 | 62 | $2,480 | $1,603 | 64.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 13 | 14 | $1,190 | $511.99 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 164 | $30,240 | $13,489 | 44.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 100 | 100 | $18,500 | $13,464 | 72.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 73 | 115 | $14,375 | $7,182 | 50.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 59 | 89 | $11,125 | $6,557 | 58.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 24 | $6,000 | $3,144 | 52.4% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 20 | 23 | $4,255 | $2,574 | 60.5% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 35 | 52 | $2,080 | $1,402 | 67.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 17 | 17 | $1,445 | $643.99 | 44.6% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 12 | 13 | $1,115 | $556.59 | 49.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $840.00 | $118.64 | 14.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 116 | 186 | $34,025 | $17,482 | 51.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 82 | 82 | $15,010 | $11,397 | 75.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 86 | 144 | $17,760 | $9,773 | 55.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 64 | 89 | $16,465 | $9,051 | 55.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 26 | 29 | $3,625 | $2,010 | 55.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 11 | $2,750 | $1,676 | 61.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 29 | 32 | $2,885 | $1,139 | 39.5% |
About Dr. Munawar Azam, MD
Dr. Munawar Azam, MD is a Internal Medicine healthcare provider based in Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1104859271.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Munawar Azam, MD has received a total of $9,846 in payments from pharmaceutical and medical device companies, with $1,047 received in 2024. These payments were reported across 512 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($9,605).
As a Medicare-enrolled provider, Azam has provided services to 1,672 Medicare beneficiaries, totaling 2,496 services with total Medicare billing of $195,619. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Warwick, RI
- Active Since 07/09/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1104859271
Products in Payments
- FARXIGA (Drug) $709.47
- JARDIANCE (Drug) $583.96
- XARELTO (Drug) $470.44
- Ozempic (Drug) $429.47
- TRELEGY ELLIPTA (Drug) $408.66
- UBRELVY (Drug) $376.21
- TRULICITY (Drug) $345.47
- QULIPTA (Drug) $240.42
- CONTRAVE (Drug) $239.19
- INVOKANA (Drug) $234.55
- JANUVIA (Drug) $194.07
- Wegovy (Drug) $193.31
- VIBERZI (Drug) $177.26
- TRADJENTA (Drug) $175.43
- LINZESS (Drug) $173.64
- BEVESPI AEROSPHERE (Drug) $172.16
- EMGALITY (Drug) $167.52
- SYMBICORT (Drug) $159.98
- BREZTRI (Drug) $158.61
- SOLIQUA 100/33 (Biological) $153.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Warwick
Dr. Arnav Kumar, Md, MD
Internal Medicine — Payments: $31,845
Internal Medicine $31,845
Shuangping Wang, M.d, M.D
Internal Medicine — Payments: $12,925
Internal Medicine $12,925
Dr. Vikram Malik, Md, MD
Internal Medicine — Payments: $9,694
Internal Medicine $9,694
Matthew Ethier, Md, MD
Internal Medicine — Payments: $6,800
Internal Medicine $6,800
Kimberly Humulock, Do, DO
Internal Medicine — Payments: $3,874
Internal Medicine $3,874
Dr. Anthony Martini, Md, MD
Internal Medicine — Payments: $3,751
Internal Medicine $3,751